Development of Small Molecules to Promote Remyelination in Multiple Sclerosis

Therapeutic Innovation Australia 2026 Open access

Read full text
Authors: Therapeutic Innovation Australia
DOI: 10.82292/wdt2-hx72
Cited by: 0

Fields of Study & Subjects

Multiple Sclerosis Research Studies Neurogenesis and neuroplasticity mechanisms Sphingolipid Metabolism and Signaling

Publication details

Journal / source
Therapeutic Innovation Australia
Publication date
16 February 2026
Language
EN